|
|
 |
|
| | |
| | | | | | | | | |
gene
|
|
PR:000003847 |
angiotensinogen
|
AGT
|
"A serpin that is a translation product of the human AGT gene or a 1:1 ortholog thereof." [PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | | | | | |
organism-gene
|
|
PR:P01015 |
angiotensinogen (rat)
|
rAGT
|
"An angiotensinogen that is encoded in the genome of rat." [OMA:P01015, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-sequence
|
|
PR:P01015-1 |
angiotensinogen isoform 1 (rat)
|
rAGT/iso:1
|
"An angiotensinogen isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | |
organism-gene
|
|
PR:P01019 |
angiotensinogen (human)
|
hAGT
|
"An angiotensinogen that is encoded in the genome of human." [PRO:CNA, UniProtKB:P01019]
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000046285 |
angiotensinogen, signal peptide removed form (human)
|
hAGT/SigPep-
|
"An angiotensinogen (human) that has had the signal peptide removed. UniProtKB:P01019, 25-476." [PRO:DNx, Reactome:R-HSA-1998759]
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000051442 |
angiotensinogen N-glycosylated 1 (human)
|
hAGT/NGlyco:1
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G00912UN." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000051443 |
angiotensinogen N-glycosylated 2 (human)
|
hAGT/NGlyco:2
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G08293MJ." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000051444 |
angiotensinogen N-glycosylated 3 (human)
|
hAGT/NGlyco:3
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G10486CT." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000051445 |
angiotensinogen N-glycosylated 4 (human)
|
hAGT/NGlyco:4
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G27947YN." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000051446 |
angiotensinogen N-glycosylated 5 (human)
|
hAGT/NGlyco:5
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G40926MX. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G40926MX." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000051447 |
angiotensinogen N-glycosylated 6 (human)
|
hAGT/NGlyco:6
|
"An angiotensinogen (human) that has been N-glycosylated at the residue equivalent to Asn-47 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P01019-1, Asn-47, MOD:00160~GNO:G59626AS." [GlyGen:P01019-1, PMID:29671580, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000051448 |
angiotensinogen O-glycosylated 1 (human)
|
hAGT/OGlyco:1
|
"An angiotensinogen (human) that has been O-glycosylated at the residue equivalent to Thr-440 of the amino acid sequence represented by UniProtKB:P01019-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01019-1, Thr-440, MOD:00005~GNO:G43417UB." [GlyGen:P01019-1, PMID:30459171, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | |
organism-gene
|
|
PR:P11859 |
angiotensinogen (mouse)
|
mAGT
|
"An angiotensinogen that is encoded in the genome of mouse." [OMA:P11859, PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-sequence
|
|
PR:P11859-1 |
angiotensinogen isoform 1 (mouse)
|
mAGT/iso:1
|
"An angiotensinogen isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | |
sequence
|
|
PR:000038855 |
angiotensinogen isoform 1
|
AGT/iso:1
|
"An angiotensinogen that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P11859-1 or a 1:1 ortholog thereof." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-sequence
|
|
PR:P01015-1 |
angiotensinogen isoform 1 (rat)
|
rAGT/iso:1
|
"An angiotensinogen isoform 1 that is encoded in the genome of rat." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-sequence
|
|
PR:P11859-1 |
angiotensinogen isoform 1 (mouse)
|
mAGT/iso:1
|
"An angiotensinogen isoform 1 that is encoded in the genome of mouse." [PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | | | | | | |
modification
|
|
PR:000018931 |
angiotensinogen, signal peptide removed form
|
AGT/SigPep-
|
"An angiotensinogen that has had the signal peptide removed." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
modification
|
|
PR:000018932 |
angiotensinogen proteolytic cleavage product
|
AGT/ClvPrd
|
"An angiotensinogen, signal peptide removed form that has been processed by proteolytic cleavage." [PRO:DNx]
|
|
|
|
|
|
|
| | | | | | | | |
| | | |
modification
|
|
PR:000036008 |
angiotensin I
|
ang I
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of renin on angiotensinogen, signal peptide removed form." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| |
modification
|
|
PR:000036009 |
angiotensin II
|
ang II
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme on angiotensin I." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
modification
|
|
PR:000036010 |
angiotensin III
|
ang III
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase A on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | | | |
modification
|
|
PR:000036011 |
angiotensin IV
|
ang IV
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase M on angiotensin III." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
modification
|
|
PR:000036013 |
angiotensin 1-7
|
ang 1-7
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| |
modification
|
|
PR:000036012 |
angiotensin 1-9
|
ang 1-9
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin I." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | |
modification
|
|
PR:000036009 |
angiotensin II
|
ang II
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme on angiotensin I." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| |
modification
|
|
PR:000036010 |
angiotensin III
|
ang III
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase A on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
modification
|
|
PR:000036011 |
angiotensin IV
|
ang IV
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase M on angiotensin III." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| |
modification
|
|
PR:000036013 |
angiotensin 1-7
|
ang 1-7
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | |
modification
|
|
PR:000036010 |
angiotensin III
|
ang III
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase A on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| |
modification
|
|
PR:000036011 |
angiotensin IV
|
ang IV
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase M on angiotensin III." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | |
modification
|
|
PR:000036011 |
angiotensin IV
|
ang IV
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase M on angiotensin III." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | |
modification
|
|
PR:000036012 |
angiotensin 1-9
|
ang 1-9
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin I." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | |
modification
|
|
PR:000036013 |
angiotensin 1-7
|
ang 1-7
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
modification
|
|
PR:000036008 |
angiotensin I
|
ang I
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of renin on angiotensinogen, signal peptide removed form." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | |
modification
|
|
PR:000036009 |
angiotensin II
|
ang II
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme on angiotensin I." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| |
modification
|
|
PR:000036010 |
angiotensin III
|
ang III
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase A on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | | | |
modification
|
|
PR:000036011 |
angiotensin IV
|
ang IV
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of aminopeptidase M on angiotensin III." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | | | |
| |
modification
|
|
PR:000036013 |
angiotensin 1-7
|
ang 1-7
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin II." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | | | |
| | | |
modification
|
|
PR:000036012 |
angiotensin 1-9
|
ang 1-9
|
"An angiotensinogen proteolytic cleavage product that is formed via the action of angiotensin converting enzyme 2 on angiotensin I." [PMID:18793332, PRO:DAN]
|
|
|
|
|
|
|
| | | | | | |
| | | | | |
organism-modification
|
|
PR:000046285 |
angiotensinogen, signal peptide removed form (human)
|
hAGT/SigPep-
|
"An angiotensinogen (human) that has had the signal peptide removed. UniProtKB:P01019, 25-476." [PRO:DNx, Reactome:R-HSA-1998759]
|
|
|
|
|
